A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery
- PMID: 23592746
- PMCID: PMC3689286
- DOI: 10.1210/en.2012-2069
A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery
Abstract
Bariatric surgery elevates serum bile acids. Conjugated bile acid administration, such as tauroursodeoxycholic acid (TUDCA), improves insulin sensitivity, whereas short-circuiting bile acid circulation through ileal interposition surgery in rats raises TUDCA levels. We hypothesized that bariatric surgery outcomes could be recapitulated by short circuiting the normal enterohepatic bile circulation. We established a model wherein male obese rats underwent either bile diversion (BD) or Sham (SH) surgery. The BD group had a catheter inserted into the common bile duct and its distal end anchored into the middistal jejunum for 4-5 weeks. Glucose tolerance, insulin and glucagon-like peptide-1 (GLP-1) response, hepatic steatosis, and endoplasmic reticulum (ER) stress were measured. Rats post-BD lost significantly more weight than the SH rats. BD rats gained less fat mass after surgery. BD rats had improved glucose tolerance, increased higher postprandial glucagon-like peptide-1 response and serum bile acids but less liver steatosis. Serum bile acid levels including TUDCA concentrations were higher in BD compared to SH pair-fed rats. Fecal bile acid levels were not different. Liver ER stress (C/EBP homologous protein mRNA and pJNK protein) was decreased in BD rats. Bile acid gavage (TUDCA/ursodeoxycholic acid [UDCA]) in diet-induced obese rats, elevated serum TUDCA and concomitantly reduced hepatic steatosis and ER stress (C/EBP homologous protein mRNA). These data demonstrate the ability of alterations in bile acids to recapitulate important metabolic improvements seen after bariatric surgery. Further, our work establishes a model for focused study of bile acids in the context of bariatric surgery that may lead to the identification of therapeutics for metabolic disease.
Figures
Comment in
-
Obesity: Bile acids and bariatric surgery.Nat Rev Endocrinol. 2013 Jul;9(7):379. doi: 10.1038/nrendo.2013.97. Epub 2013 May 7. Nat Rev Endocrinol. 2013. PMID: 23648872 No abstract available.
-
Are bile acids the new gut hormones? Lessons from weight loss surgery models.Endocrinology. 2013 Jul;154(7):2255-6. doi: 10.1210/en.2013-1383. Endocrinology. 2013. PMID: 23794408 No abstract available.
Similar articles
-
Bile acid profiles within the enterohepatic circulation in a diabetic rat model after bariatric surgeries.Am J Physiol Gastrointest Liver Physiol. 2018 May 1;314(5):G537-G546. doi: 10.1152/ajpgi.00311.2017. Epub 2017 Dec 21. Am J Physiol Gastrointest Liver Physiol. 2018. PMID: 29351394
-
Bile-acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefits of ileal interposition surgery in UCD-T2DM rats.Dis Model Mech. 2013 Mar;6(2):443-56. doi: 10.1242/dmm.010421. Epub 2012 Dec 20. Dis Model Mech. 2013. PMID: 23264565 Free PMC article.
-
Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities.Am J Physiol Gastrointest Liver Physiol. 2010 Sep;299(3):G652-60. doi: 10.1152/ajpgi.00221.2010. Epub 2010 Jul 1. Am J Physiol Gastrointest Liver Physiol. 2010. PMID: 20595624 Free PMC article.
-
Tauroursodeoxycholate-Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives.Cells. 2019 Nov 20;8(12):1471. doi: 10.3390/cells8121471. Cells. 2019. PMID: 31757001 Free PMC article. Review.
-
Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?Dig Dis. 2015;33(3):440-6. doi: 10.1159/000371699. Epub 2015 May 27. Dig Dis. 2015. PMID: 26045281 Free PMC article. Review.
Cited by
-
Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease.Front Endocrinol (Lausanne). 2023 Jul 25;14:1169624. doi: 10.3389/fendo.2023.1169624. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37560311 Free PMC article. Review.
-
Effects of bariatric surgery on drug pharmacokinetics-Preclinical studies.Front Pharmacol. 2023 Apr 5;14:1133415. doi: 10.3389/fphar.2023.1133415. eCollection 2023. Front Pharmacol. 2023. PMID: 37089960 Free PMC article. Review.
-
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.Front Nutr. 2023 Mar 2;10:1120168. doi: 10.3389/fnut.2023.1120168. eCollection 2023. Front Nutr. 2023. PMID: 36937361 Free PMC article. Review.
-
Comparing Transcriptomes Reveals Key Metabolic Mechanisms in Superior Growth Performance Nile Tilapia (Oreochromis niloticus).Front Genet. 2022 Jul 12;13:879570. doi: 10.3389/fgene.2022.879570. eCollection 2022. Front Genet. 2022. PMID: 35903360 Free PMC article.
-
Effects of acute administration of trimethylamine N-oxide on endothelial function: a translational study.Sci Rep. 2022 May 23;12(1):8664. doi: 10.1038/s41598-022-12720-5. Sci Rep. 2022. PMID: 35606406 Free PMC article.
References
-
- Xanthakos SA, Miles L, Bove K, Inge T. Outcome of nonalcoholic fatty liver disease (NAFLD) in adolescents after bariatric surgery. (Obesity Society Annual Meeting, New Orleans, Louisiana). Obesity (Silver Spring). 2007;15:A209
-
- Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;26:497–504 - PubMed
-
- Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–752 - PubMed
-
- Nakatani H, Kasama K, Oshiro T, Watanabe M, Hirose H, Itoh H. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 2009;58:1400–1407 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
